Method of screening compounds that inhibit lysophosphatidic acid acyltransferase
US6670143B2 · kind B2 · utility
0Cited by
2References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 5, 2001 |
| Grant date | Dec 30, 2003 |
| Priority date | — |
| Expiry date | Oct 5, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N9/1029
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Polypeptides are obtained, for example, via expression of encoding cDNA sequences, that have the activity of the enzyme lysophosphatidic acid acyltransferase (LPAAT), also known as 1-acyl sn-glycerol-3-phosphate acyltransferase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.